/Labcorp%20Holdings%20Inc_%20location-by%20Sundry%20Photography%20via%20iStock.jpg)
With a market cap of $20.3 billion, Labcorp Holdings Inc. (LH) is a leading healthcare diagnostics company offering a broad range of clinical laboratory and drug development services. Through its Diagnostics Laboratories and Biopharma Laboratory Services segments, Labcorp supports healthcare providers, pharmaceutical companies, and patients with critical testing, research, and diagnostic solutions.
Shares of the Burlington, North Carolina-based company have outperformed the broader market over the past 52 weeks. LH has increased 23.1% over this time frame, while the broader S&P 500 Index ($SPX) has gained 10.2%. Moreover, Labcorp stock has risen 5.8% on a YTD basis, compared to SPX's 1.3% decline.